By combining the prediction results from SCENIC and the JASPAR database, the expression differences between tumor and normal tissues, and correlating these with prognosis, we finally deduced E2F3 may be the key transcription factor and verified this by luciferase reporter gene assays. This evidence concerns the gene E2F3 and neoplasm.